Chifei Kang

About Chifei Kang

Chifei Kang, With an exceptional h-index of 7 and a recent h-index of 6 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Cardiovascular disease, diabetes, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis

TMEM176B regulates AKT/mTOR signaling and tumor growth in triple-negative breast cancer

The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms

SUN-131 the roles of two insulin receptor isoforms in triple negative breast cancer growth

SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression

Chifei Kang Information

University

Position

___

Citations(all)

361

Citations(since 2020)

316

Cited By

153

hIndex(all)

7

hIndex(since 2020)

6

i10Index(all)

7

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Chifei Kang Skills & Research Interests

Cardiovascular disease

diabetes

cancer

Top articles of Chifei Kang

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis

Journal of the Endocrine Society

2023/10

Chifei Kang
Chifei Kang

H-Index: 6

TMEM176B regulates AKT/mTOR signaling and tumor growth in triple-negative breast cancer

Cells

2021/12/6

The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms

2020/12/1

Chifei Kang
Chifei Kang

H-Index: 6

SUN-131 the roles of two insulin receptor isoforms in triple negative breast cancer growth

Journal of the Endocrine Society

2020/4

Chifei Kang
Chifei Kang

H-Index: 6

SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression

Journal of the Endocrine Society

2020/4

Chifei Kang
Chifei Kang

H-Index: 6

See List of Professors in Chifei Kang University(Icahn School of Medicine at Mount Sinai)